Advanced Prostate Cancer

Changes of PSA Doubling Time is Associated with Disease Progression in Men with Biochemically Relapsed Prostate Cancer Treated with Intermittent Androgen Deprivation

Researchers at the The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, Maryland studied the relationship between the change of PSA doubling time (PSADT) and disease progression during intermittent androgen deprivation (IAD) therapy for prostate cancer. They retrospectively analyzed the data from 96 men diagnosed with biochemically relapsed prostate cancer (BRPC) who [...]

By Malecare|2017-10-19T10:53:12-04:00April 17th, 2011|Advanced Prostate Cancer, Drugs & Treatments, Hormone Therapy, Uncategorized, Understanding APC|0 Comments

Pomegranate and Its Role In PSA Velocity

In 2005 there was a small clinical trial performed at UCLA evaluating pomegranate juice and its ability to control PSA for men with prostate cancer. The trial gave 8 oz. of POM Wonderful pomegranate juice each day in men with a rising PSA post treatment (recurrent advanced prostate cancer). This trial, which was funded by [...]

By Malecare|2020-02-04T10:12:43-05:00April 11th, 2011|Advanced Prostate Cancer, Clinical Trials, Clinical Trials, Diet and Supplements, General Information, How We Live, Me, Research, Uncategorized, Understanding APC|1 Comment

Status Update on the Budget and It’s Implications for Cancer Research

As of now, Congress and the Administration are at an impasse on FY 11 spending. If no deal is reached by Friday, government operations will shut down. This would impact cancer research and prevention programs in the following ways: * Patient enrollment in clinical trials would be discontinued; * No new grants would be awarded; [...]

By Malecare|2017-10-19T10:53:13-04:00April 6th, 2011|Advanced Prostate Cancer, Advocacy, Clinical Trials, Clinical Trials, Uncategorized|1 Comment

Dendreon Gets FDA Approval for Extra Work Stations at their New Jersey Factory

On March 10th (my birthday) Dendreon announced that it has obtained clearance of its new work stations from the FDA. The result of this clearance is the quadrupling the output from the New Jersey factory where it makes sipuleucel-T (Provenge). When Dendreon obtained FDA clearance in April of 2010, it had extremely limited manufacturing capabilities [...]

By Malecare|2011-04-06T12:16:49-04:00April 6th, 2011|Advanced Prostate Cancer, Drugs & Treatments, General Information, Uncategorized, Understanding APC, vaccines|0 Comments

Update On the Status of Funding for the DoD for fiscal 2011

There has been some movement in the House of Representatives pertaining to the issue of future funding for the Department of Defense Prostate Cancer Research Program (DoD). The budget debate continues to slog on. We still could see an eventual governmental shut down if the members of congress are still unable to either pass a [...]

By Malecare|2021-02-17T11:03:30-05:00April 5th, 2011|Advanced Prostate Cancer, Advocacy, DOD, Financial, Research, Uncategorized|0 Comments